MedPath

Caffeine

Generic Name
Caffeine
Brand Names
Anacin, Arthriten Inflammatory Pain, Ascomp, Bc Arthritis, Bc Original Formula, Cafcit, Diurex, Dvorah, Esgic, Exaprin, Excedrin, Excedrin Tension Headache, Fioricet, Fioricet With Codeine, Fiorinal, Goody's Extra Strength, Goody's Headache Relief Shot, Goody's PM, Midol Complete, Midol Cramps & Bodyaches, Migergot, Norgesic, Norgesic Forte, Orbivan, Orphengesic, Pamprin Max Formula, Peyona, Stanback Headache Powder Reformulated Jan 2011, Trezix, Trianal, Trianal C, Triatec, Triatec-8, Vanatol, Vanatol S, Vanquish, Vivarin, Peyona (previously Nymusa), Gencebok
Drug Type
Small Molecule
Chemical Formula
C8H10N4O2
CAS Number
58-08-2
Unique Ingredient Identifier
3G6A5W338E
Background

Caffeine is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. Caffeine is similar in chemical structure to Theophylline and Theobromine. It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, which are different than coffee beans. Caffeine is also used in a variety of cosmetic products and can be administered topically, orally, by inhalation, or by injection.

The caffeine citrate injection, used for apnea of the premature newborn, was initially approved by the FDA in 1999. According to an article from 2017, more than 15 million babies are born prematurely worldwide. This correlates to about 1 in 10 births. Premature birth can lead to apnea and bronchopulmonary dysplasia, a condition that interferes with lung development and may eventually cause asthma or early onset emphysema in those born prematurely. Caffeine is beneficial in preventing and treating apnea and bronchopulmonary dysplasia in newborns, improving the quality of life of premature infants.

Indication

Caffeine is indicated for the short term treatment of apnea of prematurity in infants and off label for the prevention and treatment of bronchopulmonary dysplasia caused by premature birth. In addition, it is indicated in combination with sodium benzoate to treat respiratory depression resulting from an overdose with CNS depressant drugs. Caffeine has a broad range of over the counter uses, and is found in energy supplements, athletic enhancement products, pain relief products, as well as cosmetic products.

Associated Conditions
Acute Pain, Chronic Lung Disease of Prematurity, Common Cold, Dyspepsia, Fatigue, Fever, Flu caused by Influenza, Headache, Menstrual Pain, Myalgia, Pain, Pain caused by Rheumatism, Primary apnea of premature newborns, Respiratory Depression, Somnolence, Tension Headache, Toothache, Under-eyes Dark Circles, Vascular Headaches, Moderate Pain
Associated Therapies
Analgesia, Antacid therapy, Athletic Performance

Testing Potential Synergistic Effects of Albuterol and Caffeine on Metabolic Rate

First Posted Date
2014-05-12
Last Posted Date
2015-12-18
Lead Sponsor
Pennington Biomedical Research Center
Target Recruit Count
8
Registration Number
NCT02135965
Locations
🇺🇸

Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States

A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and Caffeine

Phase 1
Completed
Conditions
Pharmacokinetics of Repaglinide
Pharmacokinetics of Caffeine
Healthy Subjects
Interventions
First Posted Date
2014-05-01
Last Posted Date
2014-05-01
Lead Sponsor
Astellas Pharma Global Development, Inc.
Target Recruit Count
24
Registration Number
NCT02128321
Locations
🇺🇸

Parexel Early Phase Clinical Unit, Baltimore, Maryland, United States

EIMD Mechanisms Causing Force Loss

Phase 1
Terminated
Conditions
Healthy
Interventions
Other: Flour
First Posted Date
2014-04-29
Last Posted Date
2017-06-05
Lead Sponsor
University of Oklahoma
Target Recruit Count
3
Registration Number
NCT02125643
Locations
🇺🇸

Sensory and Muscle Function Lab 7, Norman, Oklahoma, United States

Gender Difference in Response to Caffeine in Children and Adolescents

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2014-04-21
Last Posted Date
2022-08-17
Lead Sponsor
State University of New York at Buffalo
Target Recruit Count
101
Registration Number
NCT02119416
Locations
🇺🇸

State University at New York at Buffalo, Buffalo, New York, United States

The Effects of Caffeine on Pain-Based Pacing During a Cycling Time-Trial

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2014-04-16
Last Posted Date
2017-06-05
Lead Sponsor
University of Oklahoma
Target Recruit Count
15
Registration Number
NCT02115763
Locations
🇺🇸

University of Oklahoma Sensory and Muscle Function Lab, Norman, Oklahoma, United States

High Versus Low Dose of Caffeine for Apnea of Prematurity

Phase 3
Completed
Conditions
Apnea
Preterm Infants
Interventions
First Posted Date
2014-04-04
Last Posted Date
2014-04-04
Lead Sponsor
Mansoura University Children Hospital
Target Recruit Count
120
Registration Number
NCT02103777
Locations
🇪🇬

Mansoura University Children Hospital, Mansoura, El Dakahlya, Egypt

Inhibition of VAP-1 by Caffeine in Healthy Human Volunteers Study

Phase 1
Withdrawn
Conditions
Liver Disease
Interventions
First Posted Date
2014-03-28
Last Posted Date
2018-04-19
Lead Sponsor
University of Birmingham
Registration Number
NCT02098785
Locations
🇬🇧

University of Birmingham, UK, Birmingham, West Midlands, United Kingdom

A Study of Caffeine on Cardiac Arrhythmias

Not Applicable
Completed
Conditions
Supraventricular Tachycardia (SVT)
Atrial Fibrillation
Interventions
Other: Placebo
First Posted Date
2014-03-24
Last Posted Date
2016-12-22
Lead Sponsor
Ottawa Heart Institute Research Corporation
Target Recruit Count
160
Registration Number
NCT02095405
Locations
🇨🇦

University of Ottawa Heart Institute, Ottawa, Ontario, Canada

Effect on Energy Metabolism at Cellular Level of Diet Plus Treatment With Ephedrine and Caffeine in Obesity

Phase 3
Completed
Conditions
Obesity
Interventions
Drug: Placebo
Other: Hypocaloric diet
First Posted Date
2014-01-29
Last Posted Date
2014-01-29
Lead Sponsor
Istituto Auxologico Italiano
Target Recruit Count
13
Registration Number
NCT02048215
Locations
🇮🇹

Istituto Auxologico Italiano -Ospedale San Giuseppe, Verbania, VB, Italy

© Copyright 2025. All Rights Reserved by MedPath